Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids

被引:68
作者
McCarthy, TC [1 ]
Li, XF [1 ]
Sinal, CJ [1 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 1X5, Canada
关键词
D O I
10.1074/jbc.M411520200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The multidrug resistance-associated protein 3 (MRP3) is a multispecific anion transporter that is capable of transporting a number of conjugated and unconjugated bile acids. Expression of the MRP3 gene is increased during pathological states associated with elevated bile acid concentrations indicating a role for this transporter in adaptive and homeostatic bile acid metabolism. Analysis of Mrp3 mRNA levels in various mouse tissues with known relevance and/or exposure to bile acids revealed the highest levels of basal expression in the colon followed in order by the liver, duodenum, jejunum, ileum, and kidney. Functional analysis of a murine Mrp3 promoter reporter construct revealed vitamin D receptor (VDR)-dependent activation by 1,25-dihydroxyvitamin D-3 (VD3), 9-cis-retinoic acid (RA), and the cholestatic secondary bile acid, lithocholic acid (LCA). Using a series of deletion constructs combined with sequence analysis, a candidate VDR response element (VDRE) was identified between -1028 and -1014 bp of the Mrp3 promoter. Activation of the Mrp3 promoter in response to VD3, RA, or LCA, as well as binding of VDR/RXR heterodimers, was attenuated substantially by mutation of this VDRE. Treatment of mice with VD3 or LCA demonstrated in vivo modulation of the Mrp3 gene in colon but not in the liver. Reduction of endogenous VDR expression in colon adenocarcinoma MCA-38 cells by siRNA transfection was associated with reduced constitutive and inducible expression of the Mrp3 gene. These data support a regulatory role for the VDR in the protection of colon cells from bile acid toxicity through regulation of the Mrp3 expression.
引用
收藏
页码:23232 / 23242
页数:11
相关论文
共 55 条
[1]   Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases [J].
Adorini, L .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (07) :1017-1028
[2]   P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[3]   Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis [J].
Baijal, PK ;
Fitzpatrick, DW ;
Bird, RP .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 31 (02) :81-89
[4]  
Batta AK, 1999, J LIPID RES, V40, P1148
[5]  
Benedetti A, 1997, HEPATOLOGY, V26, P9
[6]   Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis [J].
Bohan, A ;
Chen, WS ;
Denson, LA ;
Held, MA ;
Boyer, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36688-36698
[7]   Molecular advances in the etiology and treatment of colorectal cancer [J].
Bradley, BA ;
Evers, BM .
SURGICAL ONCOLOGY-OXFORD, 1997, 6 (03) :143-156
[8]   ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption [J].
Brousseau, ME .
CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (01) :35-40
[9]   Multidrug resistance ABC transporters [J].
Chang, G .
FEBS LETTERS, 2003, 555 (01) :102-105
[10]   Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes [J].
Drocourt, L ;
Ourlin, JC ;
Pascussi, JM ;
Maurel, P ;
Vilarem, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25125-25132